2015
Effect of Zinc & Multiple Micronutrient Supplements on Growth in Tanzanian Children
Locks L, Manji K, McDonald C, Kupka R, Kisenge R, Aboud S, Wang M, Spiegelman D, Fawzi W, Duggan C. Effect of Zinc & Multiple Micronutrient Supplements on Growth in Tanzanian Children. The FASEB Journal 2015, 29 DOI: 10.1096/fasebj.29.1_supplement.729.1.Peer-Reviewed Original ResearchDouble-blind clinical trialBlind clinical trialMultiple micronutrient supplementsAge 6 weeksRate of underweightRisk of mortalityGrowth of infantsAge z-scorePoor child growthMonths of ageRates of stuntingMedian complianceTanzanian infantsMultivitamin supplementsClinical trialsMicronutrient supplementsDaily zincMean changeGrowth falteringTanzanian childrenEarly infancyMultivitaminsZ-scoreUnderweightInfants
2010
Maternal Vitamin D Status and Child Tuberculosis, Anemia, and Morbidity in Tanzania
Finkelstein J, Mehta S, Manji K, Duggan C, Mugusi F, Spiegelman D, Msamanga G, Fawzi W. Maternal Vitamin D Status and Child Tuberculosis, Anemia, and Morbidity in Tanzania. The FASEB Journal 2010, 24: 227.3-227.3. DOI: 10.1096/fasebj.24.1_supplement.227.3.Peer-Reviewed Original ResearchMaternal vitamin D statusVitamin D statusLow vitamin D statusD statusLow vitamin D levelsPregnant Tanzanian womenTrial of vitaminVitamin D levelsChild health outcomesAssociation of outcomesTimes greater riskProportional hazards modelMonths of ageCD4 countHIV stageChart reviewPulmonary tuberculosisRespiratory symptomsChild tuberculosisSevere anemiaD levelsLowest quintileSecond quintileAnemia outcomesLower risk
2005
Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers
Kupka R, Msamanga GI, Spiegelman D, Rifai N, Hunter DJ, Fawzi WW. Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. European Journal Of Clinical Nutrition 2005, 59: 1250-1258. PMID: 16015252, DOI: 10.1038/sj.ejcn.1602236.Peer-Reviewed Original ResearchConceptsPlasma selenium levelsMorbidity informationSelenium levelsChild mortalityMaternal vitamin supplementsMonthly clinic visitsProspective cohort studyTertiary care hospitalMuhimbili National HospitalRisk of diarrheaChild health outcomesMonths of ageSelenium statusCause mortalityClinic visitsCohort studyRespiratory outcomesMedian ageStudy clinicNational HospitalVitamin supplementsHealth outcomesStudy childrenFogarty International CenterStudy participants
2002
Vitamin A Supplements Ameliorate the Adverse Effect of HIV-1, Malaria, and Diarrheal Infections on Child Growth
Villamor E, Mbise R, Spiegelman D, Hertzmark E, Fataki M, Peterson KE, Ndossi G, Fawzi WW. Vitamin A Supplements Ameliorate the Adverse Effect of HIV-1, Malaria, and Diarrheal Infections on Child Growth. Pediatrics 2002, 109: e6-e6. PMID: 11773574, DOI: 10.1542/peds.109.1.e6.Peer-Reviewed Original ResearchConceptsMid-upper arm circumferenceMonths of ageVitamin A supplementsPersistent diarrheaHIV infectionRespiratory infectionsVitamin AArm circumferenceHIV statusStudy clinicTreatment armsA supplementsHigher mid-upper arm circumferenceHuman immunodeficiency virus (HIV) infectionInfectious diseasesAdverse effectsLow arm circumferenceEpisodes of infectionImmunodeficiency virus infectionDay of admissionIU vitamin APrevalence of vitaminChild growthConfidence intervalsSeverity of diarrhea
1999
A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania
FAWZI W, MBISE R, HERTZMARK E, FATAKI M, HERRERA M, NDOSSI G, SPIEGELMAN D. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. The Pediatric Infectious Disease Journal 1999, 18: 127-133. PMID: 10048684, DOI: 10.1097/00006454-199902000-00009.Peer-Reviewed Original ResearchConceptsUninfected childrenCause mortalityChildren ages 6 monthsMortality of HIVTrial of vitaminPlacebo-controlled trialDiarrhea-related deathsAge 6 monthsWestern blot testMonths of ageEnzyme-linked immunosorbentLow-cost interventionChildren 58HIV antibodiesHospital dischargeHIV infectionHIV statusPositive childrenStandard treatmentMean durationAntigen assaysFurther dosesHuman immunodeficiencyClinical signsNeutralization assays